

HCFP/Capital Partners III LLC - CEO, founder, businessman - profile

















directorpedia.net - List of CEOs, founders, board members and company directors











HCFP/Capital Partners III LLC
Check out list of companies and businesses related to HCFP/Capital Partners III LLC. Find out HCFP/Capital Partners III LLC address and contact details. View other people related to HCFP/Capital Partners III LLC - coworkers, colleagues, companions, etc.
Address:   

420 LEXINGTON AVENUE SUITE 300 NEW YORK 10170 NY




Companies related to HCFP/Capital Partners III LLC
CIKCompany NamePositionCompany Address0001624326PAVmed Inc.ONE GRAND CENTRAL PLACE SUITE 4600 NEW YORK 10165




HCFP/Capital Partners III LLC on the Web
Persons related to HCFP/Capital Partners III LLC - PAVmed Inc.NamePositionCityLishan  AklogChairman and CEO NEW YORKDeGuzman  BrianNew YorkJames L  CoxDirector DENVERWeild,  David IVNew YorkBrian J.  DeGuzmanChief Medical Officer NEW YORKRichard F  FitzgeraldCFO and Secretary WESTMINSTERMichael J  GlennonVice Chairman NEW YORKIra Scott  GreenspanDirector NEW YORKGrenspan  IraNew YorkCox  JamesNew YorkLamstein  JoshuaNew YorkJoshua R  LamsteinDirector NEW YORKAklog  LishanNew YorkAklog  LishanNew YorkDENNIS M  MCGRATHEVP & CFO MONTGOMERYVILLEGlennon  MichaelNew YorkGlennon  MichaelNew YorkPavilion Venture Partners LLCNEW YORKFitzgerald  RichardNew YorkSalute  RichardNew YorkSparks  RonaldNew YorkRonald M  SparksDirector WENHAMDavid  Weild IVDirector MINNEAPOLIS












 









Insider Trading - Hcfp/capital Partners III LLC - Form 4 SEC Filings












Home |
Archives |
Products |
About |
Contact |
FAQ |



New User?
Sign Up | 
Sign In









Form 4 Filings


Insider Buys


Significant Buys


Penny StocksInsider Buying


Insider Sales




Insider Buy Sell Ratios


Stock Options


Insider TradingStock Screener


Insider TradingGraph View


Insider Watch





Sec Filings Insider Trading - Hcfp/capital Partners III LLC





Select Time period: 
1 Month
2 Months
3 Months
6 Months
1 Year
2 Years
3 Years
4 Years
All Data
 

     



google

   



yahoo!



Send this page to:  

Blog
  



Digg

  



Reddit

  



Facebook

  



Stumble

  



del.icio.us








Enter Stock Ticker Symbol or Cik:




Cik Lookup...






Search By Company or Insider Name:







"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch ==>>

What is insider trading>>



Email a friend >>...







Historical filings delayed by 6 months. New user?
Sign Up for real time data.
Existing user?
Sign In

Common stock purchase or sale:



TransactionDate
ReportedDate
Company
Symbol
InsiderRelationship
SharesTraded
AveragePrice
TotalAmount
SharesOwned
Filing




2016-11-28Purchase
2016-12-021:06 pm
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
2,777
$9.206
$25,566
5,713,879(IndirectDirect)
View


2016-11-23Purchase
2016-11-283:40 pm
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
2,200
$8.985
$19,767
5,713,879(IndirectDirect)
View


2016-11-18Purchase
2016-11-224:07 pm
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
2,300
$10.02
$23,036
5,713,879(IndirectDirect)
View


2016-08-23Purchase
2016-09-197:12 pm
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
1,300
$14.05
$18,265
5,713,879(IndirectDirect)
View


2016-09-01Purchase
2016-09-1612:01 pm
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
1,500
$13.4
$20,103
5,713,879(IndirectDirect)
View


2016-08-25Purchase
2016-09-013:19 pm
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
400
$14.3
$5,720
5,713,879(IndirectDirect)
View


2016-08-23Purchase
2016-08-253:10 pm
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
1,500
$14.22
$21,323
5,713,879(IndirectDirect)
View


2016-05-27Purchase
2016-06-013:21 pm
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
2,400
$0
$0
5,713,879(IndirectDirect)
View


2016-05-25Purchase
2016-05-271:54 pm
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
4,000
$0
$0
5,713,879(IndirectDirect)
View


2016-05-23Purchase
2016-05-251:44 pm
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
4,900
$0
$0
5,713,879(IndirectDirect)
View


2016-05-19Purchase
2016-05-233:41 pm
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
3,100
$0
$0
5,713,879(IndirectDirect)
View


2016-05-17Purchase
2016-05-193:54 pm
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
2,300
$0
$0
5,713,879(IndirectDirect)
View




Stock options: Exercise, Award, Grant, Conversion



TransactionDate
ReportedDate
ExercisableExpiration
Company
Symnbol
InsiderRelationship
SharesTraded
ConversionPrice
SharesOwned
Filing




2016-11-23Purchase
2016-11-283:40 pm
2016-10-282022-01-29
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
300
$8
5,713,879(Direct)
View


2016-08-23Purchase
2016-09-197:12 pm
2016-10-282022-01-29
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
100
$6.35
5,713,879(Direct)
View


2016-09-01Purchase
2016-09-1612:01 pm
2016-10-282022-01-29
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
300
$7.992
5,713,879(Direct)
View


2016-09-01Purchase
2016-09-1612:01 pm
2016-10-282022-01-29
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
500
$6.991
5,713,879(Direct)
View


2016-09-01Purchase
2016-09-1612:01 pm
2016-10-282022-01-29
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
300
$7
5,713,879(Direct)
View


2016-09-01Purchase
2016-09-1612:01 pm
2016-10-282022-01-29
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
200
$8
5,713,879(Direct)
View


2016-08-25Purchase
2016-09-013:19 pm
2016-10-282022-01-29
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
200
$7.94
5,713,879(Direct)
View


2016-08-23Purchase
2016-08-253:10 pm
2016-10-282022-01-29
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
200
$6.301
5,713,879(Direct)
View


2016-08-23Purchase
2016-08-253:10 pm
2016-10-282022-01-29
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
500
$7.67
5,713,879(Direct)
View


2016-08-23Purchase
2016-08-253:10 pm
2016-10-282022-01-29
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
200
$6.35
5,713,879(Direct)
View


2016-08-23Purchase
2016-08-253:10 pm
2016-10-282022-01-29
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
350
$6.797
5,713,879(Direct)
View


2016-05-27Purchase
2016-06-013:21 pm
2016-10-282022-01-29
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
1,500
$5
5,713,879(Direct)
View


2016-05-27Purchase
2016-06-013:21 pm
2016-10-282022-01-29
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
900
$5
5,713,879(Direct)
View


2016-05-25Purchase
2016-05-271:54 pm
2016-10-282022-01-29
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
2,500
$5
5,713,879(Direct)
View


2016-05-25Purchase
2016-05-271:54 pm
2016-10-282022-01-29
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
1,500
$5
5,713,879(Direct)
View


2016-05-23Purchase
2016-05-251:44 pm
2016-10-282022-01-29
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
2,900
$5
5,713,879(Direct)
View


2016-05-23Purchase
2016-05-251:44 pm
2016-10-282022-01-29
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
2,000
$5
5,713,879(Direct)
View


2016-05-19Purchase
2016-05-233:41 pm
2016-10-282022-01-29
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
1,400
$5
5,713,879(Direct)
View


2016-05-19Purchase
2016-05-233:41 pm
2016-10-282022-01-29
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
1,700
$5
5,713,879(Direct)
View


2016-05-17Purchase
2016-05-193:54 pm
2016-10-282022-01-29
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
400
$5
5,713,879(Direct)
View


2016-05-17Purchase
2016-05-193:54 pm
2016-10-282022-01-29
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
100
$5
5,713,879(Direct)
View


2016-05-17Purchase
2016-05-193:54 pm
2016-10-282022-01-29
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
1,500
$5
5,713,879(Direct)
View


2016-04-28Option Award
2016-05-029:06 pm
N/AN/A
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
12,000
$0
5,713,879(Indirect)
View


2016-04-28Option Award
2016-05-029:06 pm
N/AN/A
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
87,020
$0
5,713,879(Indirect)
View


2016-04-28Option Award
2016-05-029:06 pm
N/AN/A
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
125,000
$0
5,713,879(Indirect)
View


2016-04-28Option Award
2016-05-029:06 pm
N/AN/A
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
20,000
$0
5,713,879(Indirect)
View


2016-04-28Option Award
2016-05-029:06 pm
2016-10-282022-01-29
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
12,000
$5
5,713,879(Indirect)
View


2016-04-28Option Award
2016-05-029:06 pm
2016-10-282022-01-29
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
87,020
$5
5,713,879(Indirect)
View


2016-04-28Option Award
2016-05-029:06 pm
2016-10-282022-01-29
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
125,000
$5
5,713,879(Indirect)
View


2016-04-28Option Award
2016-05-029:06 pm
2016-10-282022-01-29
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
20,000
$5
5,713,879(Indirect)
View


2016-04-28Option Award
2016-05-029:06 pm
N/A2026-04-28
Pavmed Inc.
PAVM
Aklog LishanHcfp/capital Partners III LLCPavilion Venture Partners LLCChairman and CEODirector10% Owner
278,726
$5
5,713,879(Direct)
View









    © 2005-2017 SecForm4.Com All rights reserved.
    Archives:
    2017 2016 2015 2014 2013 2012 ... 
    Fri, 28 Jul 2017 20:39:33 -0500
  

    SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
    SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC).
Terms of Use |
    Privacy Statement |
  










HCFP/Capital Partners III LLC: Private Company Information - Bloomberg








































  





















































































July 28, 2017 9:39 PM ET

Company Overview of HCFP/Capital Partners III LLC



Snapshot People




Company Overview
HCFP/Capital Partners III LLC was incorporated in 2014 and is based in New York, New York.


420 Lexington AvenueSuite 300New York, NY 10170United StatesFounded in 2014



Phone: 212-401-1951








Key Executives for HCFP/Capital Partners III LLC




Mr. Joshua R. Lamstein


      	Co-Owner
      


Age: 47
        







Mr.                                                Ira Scott Greenspan


      	Co-Owner
      


Age: 58
        







Dr. Brian J. deGuzman M.D.


      	Co-Owner
      


Age: 52
        







Dr. Lishan Aklog M.D.


      	Co-Owner
      


Age: 51
        







Mr. Michael J. Glennon


      	Co-Owner
      


Age: 51
        




Compensation as of Fiscal Year 2017. 



Similar Private Companies By Industry



Company Name
Region



 	Aryzta Us Holdings I Corp. United States 	Michael Anthony Hernandez, A Professional Corp United States !SOLUTIONS! Group United States "Atlantic Tele-Satellite, Inc. United States "D" Construction, Inc. United States




Recent Private Companies Transactions



TypeDate
Target



No transactions available in the past 12 months.




Request Profile Update

















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



Most Searched Private Companies



Company Name
Geographic Region



 Lawyers Committee for Civil Rights Under Law United States NYC2012, Inc. United States The Advertising Council, Inc. United States Bertelsmann AG Europe Rush University United States













Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact HCFP/Capital Partners III LLC, please visit --.  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close


























 


About Capital Partners





































Capital Partners is a private investment firm founded in 1982. Our principals have invested in more than 80 platform and add-on acquisitions.  We focus primarily on manufacturers, value-added distributors and business service companies.  We have invested in and have interest in  a variety of industries, including:


Aftermarket automotive and truck parts
Claims management
Environmental services
Food processing
Furniture
Heat recovery
Hobbies and crafts
Hospitality
Infrastructure
Injection molding


Labels
Linens and textiles
OEM automotive and truck parts
Packaging
Pet products
Plastic colorants
Power plant maintenance  
    





















 



Capital Partners | Private Equity Investments 



































Capital Partners is a differentiated private equity investor focused on building and growing private companies with business owners.











LOW LEVERAGE approach

Capitalize our businesses with 60%-100% equity
Single debt class with long amortization,  flexible covenants and low interest rates
Moderates lender covenant pressure
Provides management with the flexibility to  pursue acquisitions and fund capital expansion 





HIGHER-EQUITY, LONGER TERM investment horizon

Partner with business owners and management teams for longer term  value creation
Target investment period of five to ten years





CURRENT INCOME IN ADDITION TO LONGER-TERM EQUITY GAINS

Provides business owners and management teams a quarterly cash distribution on their investment in addition to opportunity to participate in future equity gains

Current cash yield supports longer-term investment approach






Partnership and              INCENTIVE ALIGNMENT

We invest on the same terms as business owners and managers

Augment direct management ownership with equity incentives to provide opportunity to participate further in current income and capital appreciation to more deeply align interests









Low leverageapproach
Long-terminvestment horizon
Currentincome focus
Partnership andincentive alignment






 
 
 
 



















	C-III Capital Partners | Paul A. Hughson






































C-III Capital Partners






Investor Login












Site
Web


Search












Investor Login



Menu


Toggle navigation


















Site
Web


Search






Home


About


Our Businesses 


Commercial Mortgage Servicing 


Properties and Notes for Sale


Primary Servicing


Special Servicing


Rating Agency Reports




Commercial Real Estate Lending


Investment Management


Property Management


Real Estate Brokerage


Online Real Estate Marketplace


Zoning Due Diligence




Leadership


News

























Paul A. Hughson



Enter Title



Executive Managing Director
C-III Capital Partners LLC

Paul Hughson is an Executive Managing Director of C-III Capital Partners. Mr. Hughson joined Island Capital Group in July 2009 and serves as an Executive Managing Director. Prior to Island Capital Group, he enjoyed a 16 year banking relationship with Island and its predecessor company, Insignia Financial Group. Hughson is also a Vice President at Anubis Advisors, which provides strategic planning, executive management, restructuring, M&A and other financial services to Island Capital Group's portfolio companies, including C-III Capital Partners.
Before his affiliation with Island, Mr. Hughson was a member of the Lehman Brother's Global Real Estate Group for 15 years where he was the head of global credit distribution. Mr. Hughson joined Lehman in 1993 to develop Lehman Brothers'; conduit securitization platform and subsequently became responsible for all of Lehman's proprietary and client based Agency CMBS and CRE CDO securitization businesses, bringing over $100B of new issue securitized product to market. He became the head of Lehman Brothers'; Bridge Equity business in 2004 and successfully redistributed approximately $4B of real estate equity into the institutional marketplace.
From 1986 through 1993, Mr. Hughson practiced real estate law with Thacher Proffitt & Wood. Mr. Hughson received his J.D. from the University of Virginia and his B.A. from Tufts University.























    PAVMW Key Statistics - PAVmed Inc. Wt Financial Ratios - MarketWatch




































Bulletin






Investor Alert





















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































PAVmed Inc. Wt

                  NASDAQ: PAVMW
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

PAVmed Inc. Wt



Market closed
 --Quotes are delayed by 20 min
Jul 28, 2017, 2:58 p.m.


PAVMW

/quotes/zigman/75042173/composite


$
1.20




Change

-0.01
-0.83%

Volume
Volume 600
Quotes are delayed by 20 min








/quotes/zigman/75042173/composite
Previous close

$
			1.21
		


$
				1.20
			
Change

-0.01
-0.83%





Day low
Day high
$1.08
$1.20










52 week low
52 week high

            $1.00
        

            $8.00
        

















			Company Description 
		


                PAVmed, Inc. is a medical device company organized to conceive, develop and commercialize a pipeline of medical products. Its products portfolio include DisappEAR, PORTIO, Caldus, Carpx, NextCath and NextFlo. PAVmed was founded on June 26, 2014 and is headquartered in New York, NY.
            




Valuation

P/E Current
-9.05


P/E Ratio (with extraordinary items)
-5.74


Enterprise Value to EBITDA
-9.21

Efficiency

Income Per Employee
-1,883,617.00

Liquidity

Current Ratio
0.62


Quick Ratio
0.62


Cash Ratio
0.49



Profitability

Return on Assets
-542.18


Return on Equity
-3,589.54


Return on Total Capital
-3,589.54


Return on Invested Capital
-3,589.54

Capital Structure




      Officers and Executives
    



Name
Age
Officer Since
Title





Dr. Lishan  Aklog 
50
2014
Chairman & Chief Executive Officer



Mr. Dennis M. McGrath 
60
2017
Chief Financial Officer, Secretary & EVP



Dr. Brian J. deGuzman 
52
2014
Chief Medical Officer & Executive Vice President



Mr. Ira Scott Greenspan 
57
2015
Director



Mr. Michael J. Glennon 
50
2014
Vice Chairman





Insider Actions


 – Purchase

 – Sale
1
 – Number of Transactions











{"OrganizationDocuments":[{"Documents":[{"document":[{"reportDateGroup":[{"reportDate":"2011-06-09","tradeTypeGroup":[{"numTransactions":"5","tradeType":"A"}]},{"reportDate":"2011-05-17","tradeTypeGroup":[{"numTransactions":"3","tradeType":"D"},{"numTransactions":"1","tradeType":"A"}]},{"reportDate":"2011-05-16","tradeTypeGroup":[{"numTransactions":"2","tradeType":"D"},{"numTransactions":"8","tradeType":"A"}]},{"reportDate":"2011-05-13","tradeTypeGroup":[{"numTransactions":"1","tradeType":"D"}]},{"reportDate":"2011-05-12","tradeTypeGroup":[{"numTransactions":"1","tradeType":"D"}]},{"reportDate":"2011-05-11","tradeTypeGroup":[{"numTransactions":"1","tradeType":"D"}]},{"reportDate":"2011-05-02","tradeTypeGroup":[{"numTransactions":"1","tradeType":"D"}]},{"reportDate":"2011-03-10","tradeTypeGroup":[{"numTransactions":"5","tradeType":"A"}]},{"reportDate":"2011-02-17","tradeTypeGroup":[{"numTransactions":"4","tradeType":"D"},{"numTransactions":"2","tradeType":"A"}]},{"reportDate":"2011-02-15","tradeTypeGroup":[{"numTransactions":"8","tradeType":"A"},{"numTransactions":"1","tradeType":"D"}]}]}]}]}]}


Date
Name
Shares
Transaction
Value





12/09/2016

Ira Scott Greenspan 
Director

282


 



2,388


11/23/2016

Ira Scott Greenspan 
Director

110


 



988


11/18/2016

Joshua R. Lamstein 
Director

100


 
Acquisition at $11.51 per share.


1,151


11/18/2016

Joshua R. Lamstein 
Director

100


 
Acquisition at $10.38 per share.


1,038


11/18/2016

Ira Scott Greenspan 
Director

200


 



2,040


06/01/2016

Richard F. Fitzgerald                            
CFO and Secretary

200


 
Acquisition at $0 per share.


0


05/25/2016

Richard F. Fitzgerald                            
CFO and Secretary

100


 
Acquisition at $0 per share.


0


04/28/2016

Hcfp Capital Partners Iii LLC                            


20,000


 
Award at $0 per share.


0


04/28/2016

Hcfp Capital Partners Iii LLC                            


125,000


 
Award at $0 per share.


0


04/28/2016

Hcfp Capital Partners Iii LLC                            


87,020


 
Award at $0 per share.


0


04/28/2016

Ira Scott Greenspan 
Director

20,000


 
Award at $0 per share.


0


04/28/2016

Ira Scott Greenspan 
Director

125,000


 
Award at $0 per share.


0


04/28/2016

Ira Scott Greenspan 
Director

87,020


 
Award at $0 per share.


0








/news/latest/company/us/pavmw

      MarketWatch News on PAVMW
    
No News currently available for PAVMW





/news/nonmarketwatch/company/us/pavmw

      Other News on PAVMW
    
No News currently available for PAVMW










At a Glance

PAVmed, Inc.
One Grand Central Place
East 42nd Street
Suite 4600
New York, New York 10165




Phone
1 2124011951


Industry
Medical Equipment/Supplies


Sector
Health Care/Life Sciences


Fiscal Year-end
12/2017


View SEC Filings




Revenue
N/A


Net Income
$-5.65M


Employees

        3.00


Annual Report for PAVMW











/news/pressrelease/company/us/pavmw

      Press Releases on PAVMW
    




 PAVmed Inc. Postpones Business Update Conference Call to May 31st
4:35 p.m. May 16, 2017
 - BusinessWire - BZX




 PAVmed Inc. to Hold Business Update Conference Call on May 17th
8:30 a.m. May 10, 2017
 - BusinessWire - BZX




 PAVmed Announces Filing of Exchange Offer Registration Statement with 
      the SEC
4:52 p.m. April 10, 2017
 - BusinessWire - BZX




 PAVmed Announces Revised Presentation Time at the 16th Annual Needham 
      Healthcare Conference
9:00 a.m. March 31, 2017
 - BusinessWire - BZX




 PAVmed to Present at the 16th Annual Needham Healthcare Conference
7:30 a.m. March 28, 2017
 - BusinessWire - BZX




 PAVmed Announces Filing of Registration Statement Relating to Private 
      Placement
7:15 a.m. March 28, 2017
 - BusinessWire - BZX




 PAVmed Names Medical Device Industry Veteran Dennis M. McGrath as 
      Chief Financial Officer
7:30 a.m. March 21, 2017
 - BusinessWire - BZX




 PAVmed Announces Closing of Additional Financing
8:00 a.m. March 9, 2017
 - BusinessWire - BZX




 PAVmed Announces Exchange Offer
8:00 a.m. Feb. 23, 2017
 - BusinessWire - BZX




 PAVmed to Hold Business Update Conference Call and Webcast on 
      February 22nd
9:00 a.m. Feb. 17, 2017
 - BusinessWire - BZX




 PAVmed Announces Warrants Now Exercisable for Cash
5:31 p.m. Feb. 3, 2017
 - BusinessWire - BZX




 PAVmed Inc. Announces Closing of Financing
8:00 a.m. Feb. 2, 2017
 - BusinessWire - BZX




 PAVmed Files 510(k) FDA Submission for PortIO™ Intraosseous Infusion 
      System
8:00 a.m. Dec. 19, 2016
 - BusinessWire - BZX




 PAVmed to Hold Business Update Conference Call and Webcast on 
      December 7th
8:00 a.m. Dec. 2, 2016
 - BusinessWire - BZX




 PAVmed to Present at the Canaccord Genuity Medical Technologies & 
      Diagnostics Forum
5:00 p.m. Nov. 10, 2016
 - BusinessWire - BZX




 PAVmed Partners with Leading Academic Institutions to Develop 
      Revolutionary Ear Device
1:26 p.m. Nov. 4, 2016
 - BusinessWire - BZX











Trending Tickers


/quotes/zigman/17636479/composite VUZI+15.60%


/quotes/zigman/237947/composite JCP-5.83%


/quotes/zigman/59392505/composite NUGT-2.93%


/quotes/zigman/59386294/composite JNUG-5.94%


/quotes/zigman/65801738/composite TLT+1.11%


X




Powered by














Log In




9:39 PM EDT
July 28, 2017


/marketstate/country/us
New York

	Closed


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
9:16pWall Street isn’t ready for a 1,100-point tumble in the Dow industrials
7:39pBarron's Buzz: Robo 2.0, Facebook and Twitter, Trading On News
7:29pA Wild Week in Washington 
6:32pThe dark side of cruises
6:32pThe highest paid athletes in the world, in one chart
6:31pO.J. Simpson made over $400,000 while in prison and won’t have to give any of it to the Goldman family
6:31p Trump to Police: 'Don't Be Too Nice'
6:31pHere are 10 co-workers you should avoid like the plague — especially in meetings
6:29pTop 10 most annoying people you may want to unfriend on Facebook 
6:29pThis is one person you should never unfriend on Facebook...
6:29p3 horrible ways typos could alter the course of your life
6:27pPaint your bathroom this color and boost your home’s selling price by $5,400
6:27pAmericans’ new badge of honor: ‘I was blocked by a celebrity!’
6:27p5 weird things I found out about America in my first 24 hours 
6:14pBeyond Tesla: 7 stocks driving the autonomous car revolution
6:14pThese 7 highly taxed companies need Congress to finally act on tax reform
6:11pWatch out: ‘Kids’ are making the most money in this stock market 
6:10p7 real ways for millennials to save money (not by brownbagging and skipping Starbucks)
6:09p‘Game of Thrones’: This computer model predicts who will be killed off — or survive
6:09pThis basic balanced index fund is beating the hedge fund averages
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,830.31

+33.76
+0.15%





nasdaq

/quotes/zigman/12633936/realtime
6,374.68

-7.51
-0.12%





s&p 500

/quotes/zigman/3870025/realtime
2,472.10

-3.32
-0.13%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15


























































Track Hedge Funds Using 13F Filings 

































WhaleWisdom









Search All
Search 13F Filers Only
Search SEC Filer
Search Stocks Only
Search Mgmt Inv. Cos Only
ETFs Only
Search Active


















Form Type: 4







SEC EDGAR Link


Acccession Number:0001094891-16-000589


Date:2016-08-25
Issuer: PAVMED INC. (PAVM)
 Original Submission Date:


Reporting Person:
AKLOG LISHAN
    ONE GRAND CENTRAL PLACE
    SUITE 4600
    NEW YORK, NY  10165 


Reporting Person:
HCFP/CAPITAL PARTNERS III LLC
    ONE GRAND CENTRAL PLACE
    SUITE 4600
    NEW YORK, NY  10165 


Reporting Person:
PAVILION VENTURE PARTNERS LLC
    ONE GRAND CENTRAL PLACE
    SUITE 4600
    NEW YORK, NY  10165 



Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date
Transaction CodeSharesAcquired or DisposedPrice per share
5. Amount of Securities Beneficially Owned Following Reported Transaction
6. Ownership Form Direct or IndirectNature of Indirect Ownership

COMMON STOCK
2016-08-26

P
400
a
$14.30

          18,300
          
        
direct
 


COMMON STOCK



0
 
$0.00

          5,713,879
          
        
indirect
 f1


COMMON STOCK



0
 
$0.00

          2,520,532
          
        
indirect
 f2


COMMON STOCK



0
 
$0.00

          87,020
          
        
indirect
 f3


COMMON STOCK



0
 
$0.00

          125,000
          
        
indirect
 f4


COMMON STOCK



0
 
$0.00

          20,000
          
        
indirect
 f5



Derivative Securities Acquired, Disposed of, or Beneficially Owned(e.g., puts, calls, warrants, convertible securities

Title of Derivative Security 
Conversion or Exercise Price of Derivative Security
Transaction Date
Deemed Execution Date
Transaction Code
Number of Derivative Securities Acquired (A) or Disposed of (D)
Date ExercisableExpiration Date
Title and Amount of Securities Underlying Derivative Security 
Price of Derivative Security
Number of derivative Securities Beneficially Owned Following Reported Transaction(s)
Ownership Form: Direct (D) or Indirect (I)
Nature of Indirect Beneficial Ownership


WARRANTS
5.0
2016-08-25
deemed execution date
P
200 (a)
2016-10-28
2022-01-29
common stock 200
$5.00
17,850
direct
 


WARRANTS
5.0

deemed execution date

0 ( )
2016-10-28
2022-01-29
common stock 5,713,879
$5.00
5,713,879
indirect
by hcfp/capital partners iii llc


WARRANTS
5.0

deemed execution date

0 ( )
2016-10-28
2022-01-29
common stock 12,000
$5.00
2,220,532
indirect
by pavilion venture parnters llc


WARRANTS
5.0

deemed execution date

0 ( )
2016-10-28
2022-01-29
common stock 87,020
$5.00
387,020
indirect
by hcfp inc.


WARRANTS
5.0

deemed execution date

0 ( )
2016-10-28
2022-01-29
common stock 125,000
$5.00
125,000
indirect
by hcfp/capital partners iiib llc


WARRANTS
5.0

deemed execution date

0 ( )
2016-10-28
2022-01-29
common stock 20,000
$5.00
20,000
indirect
by hcfp/ag llc



Footnotes
IDfootnote

f1
dr. aklog is a member and a co-manager of hcfp/capital partners iii llc, and shares joint voting and dispositive power over the shares held by this entity. dr. aklog disclaims beneficial ownership of shares held by this entity, except to the extent of his proportionate pecuniary interest therein.


f2
dr. aklog is a member and sole manager of pavilion venture partners llc, and has sole voting and dispositive power over the shares held by this entity. dr. aklog disclaims beneficial ownership of shares held by this entity, except to the extent of his proportionate pecuniary interest therein.


f3
dr. aklog is a controlling shareholder of hcfp inc., and shares joint voting and dispositive power over the shares held by this entity. dr. aklog disclaims beneficial ownership of shares held by this entity, except to the extent of his proportionate pecuniary interest therein.


f4
dr. aklog is a member and a co-manager of the entity that acts as sole manager of hcfp/capital partners iiib llc, and shares joint voting and dispositive power over the shares held by this entity. dr. aklog disclaims beneficial ownership of shares held by this entity, except to the extent of his pecuniary interest therein.


f5
dr. aklog is a co-manager of hcfp/ag llc, and shares joint voting and dispositive power over the shares held by this entity. dr. aklog disclaims beneficial ownership of shares held by this entity, except to the extent of his pecuniary interest therein.







Elevate your investments
Try it for free
















HCFP/CAPITAL PARTNERS III LLC Top Holdings  

































WhaleWisdom









Search All
Search 13F Filers Only
Search SEC Filer
Search Stocks Only
Search Mgmt Inv. Cos Only
ETFs Only
Search Active




















                      HCFP/CAPITAL PARTNERS III LLC
                    

•   NEW YORK, NY
                      
How do I update this listing?




                                             Hcfp/capital Partners III is based out of New York.   
                                           














Summary
13D/G
Insider (Form 4)



   Create Email Alert
 




×
Email Notification.







                   ***Log In or
                   Sign-up
                   to see more advanced email alert options such as selecting any type of
                   SEC form, multiple filers or classes of filers, and much more.***
                 

                    ...or to simply have an email sent to you whenever we receive a new
                           13F filing from HCFP/CAPITAL PARTNERS III LLC, enter your
                    email address below and choose 'Submit'.
                

Your email:








Cancel














Contact Info




hcfp/capital partners iii llc


420 LEXINGTON AVENUE

NEW YORK
NY
                                                        
                                                    10170


                                                      Business Phone:
                                                      2124011951







Recent SEC Filings




4 filed on 01/12/2017
4 filed on 12/02/2016
4 filed on 11/28/2016
4 filed on 11/22/2016
4 filed on 09/19/2016
4 filed on 09/16/2016
4 filed on 09/01/2016
4 filed on 08/25/2016
4 filed on 06/01/2016
4 filed on 05/27/2016
















Schedule 13D and 13G events since 03/31/2017

Subscription required



 
Form 4 - Non-derivative Insider Transactions Since 03/31/2017
Loading...








Elevate your investments
Try it for free

















